About
Technology
Issues
FAQ
Links
Official Page
A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.